Results 181 to 190 of about 321,595 (358)
Advancements in CRISPR-based therapies for ocular pathologies: from disease mechanisms to intervention strategies. [PDF]
Li Q +7 more
europepmc +1 more source
Evolution of CRISPR technology and its implications in oral cancer diagnosis
P. Anitha +2 more
openalex +1 more source
This study reveals that the E3 ubiquitin ligase TRIM56 exacerbates neuronal ferroptosis and brain damage by mediating K48‐linked ubiquitination and degradation of KLF4, leading to suppression of the xCT/GSH/GPX4 axis. Targeting TRIM56 alleviates cerebral ischemia‐reperfusion injury in vivo and in vitro, highlighting its therapeutic potential.
Qiangping Wang +15 more
wiley +1 more source
CRISPR-Cas targeting in <i>Haloferax volcanii</i> promotes within-species gene exchange by triggering homologous recombination. [PDF]
Choudhary DK +3 more
europepmc +1 more source
Peptide dendrimers transfecting CRISPR/Cas9 plasmid DNA: optimization and mechanism
Susanna Zamolo +5 more
openalex +2 more sources
Phosphorylation of Optineurin by TBK1 induces the formation of filaments that condensate upon binding to linear polyubiquitin. Membrane‐anchored LC3 partitions into these condensates, suggesting that phase separation of filamentous Optineurin with ubiquitylated cargo promotes the sequestration of cargo and its subsequent alignment with LC3‐positive ...
Maria G. Herrera +10 more
wiley +1 more source
Activated PI3K delta syndrome 1 mutations cause neutrophilia in zebrafish larvae
Stone Elworthy +6 more
doaj +1 more source
nf-core/crisprseq: a versatile pipeline for comprehensive analysis of CRISPR gene editing and screening assays. [PDF]
Mir-Pedrol J +10 more
europepmc +1 more source
This research deciphers the m6A transcriptome by profiling its sites and functional readout effects: from mRNA stability, translation to alternative splicing, across five different cell types. Machine learning model identifies novel m6A‐binding proteins DDX6 and FXR2 and novel m6A reader proteins FUBP3 and L1TD1.
Zhou Huang +11 more
wiley +1 more source

